Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2024-07-31
Original market date: See footnote 1
2022-05-02
Product name:
JAMP CALCIUM POLYSTYRENE SULFONATE
DIN:
02502631
Product Monograph/Veterinary Labelling:
Date:
2023-01-25
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
JAMP PHARMA CORPORATION
1310 Rue Nobel
Boucherville
Quebec
Canada
J4B 5H3
Class:
Human
Dosage form(s):
Powder For Suspension
Route(s) of administration:
Rectal , Oral
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:18.18
Anatomical Therapeutic Chemical (ATC): See footnote 4
V03AE01 POLYSTYRENE SULPHONATE
Active ingredient group (AIG) number:See footnote5
0113563002
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| CALCIUM POLYSTYRENE SULFONATE | 999 MG / G |